Detailed information for compound 420722

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 361.475 | Formula: C21H31NO4
  • H donors: 2 H acceptors: 3 LogP: 3.39 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 1
  • SMILES: COCCC(C(=O)O)CC1(CCCC1)C(=O)NC(Cc1ccccc1)C
  • InChi: 1S/C21H31NO4/c1-16(14-17-8-4-3-5-9-17)22-20(25)21(11-6-7-12-21)15-18(19(23)24)10-13-26-2/h3-5,8-9,16,18H,6-7,10-15H2,1-2H3,(H,22,25)(H,23,24)
  • InChiKey: WJHYMCIIUNXORJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei protein farnesyltransferase beta subunit 0.2825 0.3488 1
Mycobacterium tuberculosis Halimadienyl diphosphate synthase 0.1408 0 0.5
Echinococcus multilocularis protein farnesyltransferase alpha subunit 0.4324 0.7174 0.5661
Schistosoma mansoni protein farnesyltransferase alpha subunit 0.4324 0.7174 0.5661
Entamoeba histolytica geranylgeranyl transferase beta subunit 0.5472 1 1
Loa Loa (eye worm) hypothetical protein 0.4324 0.7174 0.5661
Schistosoma mansoni geranylgeranyl transferase type I beta subunit 0.5472 1 1
Schistosoma mansoni geranylgeranyl transferase type I beta subunit 0.5472 1 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.4324 0.7174 0.5661
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.4324 0.7174 0.5661
Trichomonas vaginalis protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative 0.4324 0.7174 0.5661
Trichomonas vaginalis geranylgeranyl transferase type I beta subunit, putative 0.5472 1 1
Plasmodium vivax farnesyltransferase beta subunit, putative 0.2825 0.3488 0.4664
Echinococcus granulosus protein farnesyltransferase alpha subunit 0.4324 0.7174 0.5661
Giardia lamblia Rab geranylgeranyltransferase 0.4324 0.7174 1
Echinococcus multilocularis geranylgeranyl transferase type I beta subunit 0.5472 1 1
Loa Loa (eye worm) prenyltransferase and squalene oxidase repeat family protein 0.5472 1 1
Trypanosoma cruzi protein farnesyltransferase, putative 0.2825 0.3488 1
Toxoplasma gondii hypothetical protein 0.317 0.4336 1
Plasmodium vivax prenyltransferase alpha subunit, putative 0.4324 0.7174 1
Echinococcus granulosus geranylgeranyl transferase type I beta subunit 0.5472 1 1
Loa Loa (eye worm) prenyltransferase alpha subunit repeat containing protein 0.4324 0.7174 0.5661
Leishmania major farnesyltransferase beta subunit 0.2825 0.3488 0.5
Entamoeba histolytica protein farnesyltransferase alpha subunit, putative 0.4324 0.7174 0.5661
Plasmodium falciparum protein farnesyltransferase subunit alpha 0.4324 0.7174 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative 0.317 0.4336 0.1303
Brugia malayi Protein prenyltransferase alpha subunit repeat containing protein 0.4324 0.7174 0.5661
Trypanosoma cruzi protein farnesyltransferase, putative 0.2825 0.3488 1

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) > 3 uM Inhibition of pig ACE ChEMBL. 17070062
IC50 (binding) = 426 nM Inhibition of dog kidney cortex NEP at pH 7 ChEMBL. 17070062

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.